Concert Announces Milestone Achievement in GlaxoSmithKline Collaboration

Concert Pharmaceuticals today announced that it has achieved a milestone in its strategic alliance with GlaxoSmithKline for its HIV protease inhibitor (HIV-PI) development program, resulting in a $4 million milestone payment to Concert.
MarketWatch